NEW RIVER PHARMACEUTICALS INC (NRPH) is a publicly traded company in the Unknown sector. Across all available filings, 7 corporate insiders have executed 106 transactions totaling $113.4M, demonstrating a bearish sentiment with -$113.4M in net insider flow. The most recent transaction on Jan 19, 2007 involved a sale of 5,000 shares valued at $280.5K.
No significant insider buying has been recorded for NRPH in the recent period.
No significant insider selling has been recorded for NRPH in the recent period.
Based on recent SEC filings, insider sentiment for NRPH is bearish with an Insider Alignment Score of 0/100 and a net flow of -$113.4M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at NEW RIVER PHARMACEUTICALS INC (NRPH) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 7 insiders are actively trading NRPH stock, having executed 106 transactions in the past 90 days. The most active insider is River Management Ii, Lp New (Executive), who has made 23 transactions totaling $78.5M.
Get notified when executives and directors at NRPH file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 19, 2007 | E. Sobel Burton | Executive | Sale | 5,000 | $56.10 | $280.5K | |
| Jan 19, 2007 | E. Sobel Burton | Executive | Option Exercise | 5,000 | $32.71 | $163.6K | |
| Jan 3, 2007 | E. Sobel Burton | Executive | Sale | 2,500 | $54.83 | $137.1K | |
| Jan 3, 2007 | E. Sobel Burton | Executive | Option Exercise | 2,500 | $11.60 | $29.0K | |
| Jan 3, 2007 | S. Barlow David | Executive | Option Exercise | 10,000 | $3.34 | $33.4K | |
| Jan 3, 2007 | S. Barlow David | Executive | Sale | 10,000 | $54.83 | $548.3K | Large |
| Jan 3, 2007 | D. /fa Horner Larry | Executive | Option Exercise | 10,000 | $11.60 | $116.0K | |
| Jan 3, 2007 | D. /fa Horner Larry | Executive | Sale | 15,000 | $54.83 | $822.5K | Large |
| Jan 3, 2007 | D. /fa Horner Larry | Executive | Option Exercise | 5,000 | $4.00 | $20.0K | |
| Dec 4, 2006 | D. /fa Horner Larry | Executive | Option Exercise | 5,000 | $4.00 | $20.0K | |
| Dec 4, 2006 | D. /fa Horner Larry | Executive | Sale | 15,000 | $49.25 | $738.8K | Large |
| Dec 4, 2006 | D. /fa Horner Larry | Executive | Sale | 10,000 | $49.25 | $492.5K | |
| Dec 4, 2006 | D. /fa Horner Larry | Executive | Option Exercise | 10,000 | $3.33 | $33.3K | |
| Dec 1, 2006 | S. Barlow David | Executive | Option Exercise | 10,000 | $3.34 | $33.4K | |
| Dec 1, 2006 | S. Barlow David | Executive | Sale | 10,000 | $49.01 | $490.1K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 70 | $113.4M | 92.0% |
Disposition(D) | 2 | $6.2M | 5.0% |
Exercise(M) | 34 | $3.7M | 3.0% |
Insider selling pressure at NEW RIVER PHARMACEUTICALS INC has increased, with 7 insiders executing 106 transactions across all time. Total sales of $113.4M significantly outpace purchases of $0, resulting in a net outflow of $113.4M. This selling activity appears largely discretionary, which may warrant closer attention from investors.